In a previous study, infection with the mouse mammary tumor virus (MMTV) was shown to increase the sensitivity of the mammary epithelium toward prolactin (PRL); furthermore, this effect could be mimicked by the binding of the MMTV envelope protein (gp52) to its cell receptor. The present work has investigated the possibility that gp52-induced changes in the PRL receptor (PRLR) were responsible for this phenomenon. In vitro, gp52 doubled the PRLR concentration in the plasmalemma of mammary epithelium without affecting the affinity. The origins of these PRLRs were twofold: first, gp52 stimulated PRLR mRNA nearly fivefold, suggesting that some of the receptors were newly synthesized. Second, there was a redistribution of PRLRs within the mammary cell: PRLRs were shifted from an internal pool to the plasma membrane. This relocation was very rapid, occurring within 30 min. There did not appear to be any contribution from alterations in PRLR degradation, since the half-life of PRLR was not affected by gp52. In summary, the MMTV increases the PRL sensitivity of mouse mammary epithelium by elevating PRLRs through both enhanced synthesis and recruitment from microsomes.
INTRODUCTION
Receptors are the major interface between hormones and the cell, and the regulation of receptor number is an important aspect of cellular sensitivity to hormones. As such, receptor concentration is closely regulated by many factors, including hormones, developmental programs, and pathogens (Bolander 1994a) . The mouse mammary tumor virus (MMTV) is a retrovirus that infects pups through the milk of the mother; as a result, its propagation is dependent upon differentiation and lactation of the mammary gland (Nandi & McGrath 1973) . This mammary development is greatly facilitated by the fact that MMTV infection results in enhanced sensitivity toward prolactin (PRL), a major lactogenic hormone (Bolander 1994b) . It was the purpose of this work to determine the mechanism underlying this effect; in particular, the effects of MMTV on PRL receptor (PRLR) synthesis, turnover, and redistribution were investigated.
MATERIALS AND METHODS

Materials
Ovine prolactin (oPRL-19) was kindly provided by the Hormone Distribution Program, NIDDK (Bethesda, MD, USA) and crystalline porcine insulin (lot 615-08E-220) was a gift from Eli Lilly Company (Indianapolis, IN, USA). Cortisol, tri-iodothyronine (T 3 ), Hepes, cycloheximide, Nonidet P-40 (NP-40), lactoperoxidase, and protease K were purchased from Sigma Chemical Company (St Louis, MO, USA). Medium 199 with Earle's salts was obtained from Grand Island Biological Company (Grand Island, NY, USA) and collagenase, type I (179 U/mg) was from Worthington Biochemicals (Freehold, NJ, USA). The vanadyl ribonucleoside complex was purchased from Bethesda Research Laboratories (Gaithesburg, MD, USA) and Na 125 I (carrier-free) was obtained from New England Nuclear (Boston, MA, USA). gp52, the MMTV envelope protein, was prepared in the author's laboratory by the method of Marcus et al. (1979) ; milk from C3H/HeN MMTV+ mice was used as the source for the virus. Sodium dodecyl sulfate electrophoresis of the purified gp52 by the method of Weber & Osborn (1969) revealed only a single band (Fig. 1) .
Organ culture
Virgin mice (C3H/HeN MMTV+ and MMTV ) were obtained from the Frederick Cancer Research Facility (Frederick, MD, USA). The mice were killed by cervical dislocation and explants were prepared under sterile conditions from the fourth pair of glands, as previously described (Juergens et al. 1965) . Explants were cultured on siliconized lens paper in Medium 199 containing 20 m Hepes (pH 7·6) and combinations of the following reagents, as required by the individual experiment: cycloheximide (10 µg/ml), insulin (1 µg/ml), cortisol (1 µg/ml), PRL (1 µg/ml), T 3 (65 pg/ml), and/or gp52 (1 µg/ml). The concentration of gp52 was chosen so as to saturate the gp52 receptor (Bolander & Blackstone 1991) . The tissue was incubated under air at 37 C, and the medium was changed daily.
Cell isolation and membrane fractionation
PRLRs were measured on an epithelial cellenriched fraction isolated from mammary explants, as previously described (Vonderhaar et al. 1973) . Briefly, the tissue was finely minced and digested with collagenase (1·5 mg/ml Medium 199 containing 20 m Hepes (pH 7·6) and 4% (w/v) BSA) at 37 C. During this incubation, the tissue fragments were pipetted through successively smaller bore pipettes. After 30 min, the cells were centrifuged at low speed and washed three times in Medium 199 containing 20 m Hepes (pH 7·6) and 2% BSA.
When PRL binding was to be performed on membrane fractions, the epithelial cells were lysed and fractionated using the two-phase system of Brunette & Till (1971) . This technique separates the plasma membrane from other fractions, referred to here as microsomes. Purity was assessed by Na + ,K + -ATPase activity, a plasmalemma marker, and NADH diaphorase activity, a marker for the endoplasmic reticulum. Na + ,K + -ATPase activity in these two fractions was 3·9 0·7 and 0·13 0·06 µmol phosphate released/h per mg protein respectively; NADH diaphorase activity was 30 6 and 375 50 µmol NADH oxidized/min per mg protein respectively. Because receptor redistribution can occur quickly (Bolander 1994c ), a 30-min time-point was chosen; the distribution was also measured at 3 days to determine if any observed changes persisted.
PRLR assay
PRL was iodinated by a modification (Bolander & Fellows 1975) of the lactoperoxidase method of Miyachi et al. (1972) . The resulting 125 I-labeled PRL was used in binding studies, as previously  1. An SDS gel of the gp52 used in this study. The bottom of the gel was cut at the location of the bromophenol blue marker.
described (Bolander 1984) . Binding was saturable and 80% of the tracer could be dissociated upon dilution, after which the receptor could be recovered and shown to rebind approximately the same amount of 125 I-labeled PRL, suggesting that the receptor was not damaged during the 2-h incubation. The radioactivity in the supernatant could be completely precipitated by trichloroacetic acid after 2 h, suggesting that it too was not degraded.
For the PRLR half-life, mammary explants were cultured in Medium 199 with insulin, cortisol, and cycloheximide (10 µg/ml); all additives were comixed simultaneously. At various time-points, cells were isolated and total PRLRs were measured as described above.
Protein was determined by the method of Lowry et al. (1951) and binding data were analysed by the method of Scatchard (1949) . Because of the low epithelial content of mouse mammary glands, three to five animals were required to generate enough cells to construct a single Scatchard plot.
RT-PCR for PRLR mRNA
An epithelial-enriched cell fraction was prepared as described above. These cells were then lysed in 10 m Tris-HCl (pH 7·6) containing 0·5% NP-40 (Borun et al. 1967) . After the nuclei were pelleted, the cytoplasms were digested with protease K (300 µg/ml) at 37 C for 30 min and their total RNA was then extracted with phenol-chloroform (Nakhasi & Qasba 1979) in the presence of 10 m vanadyl ribonucleoside complex (Berger & Birkenmeier 1979) .
One microgram of total RNA was used as template for cDNA synthesis with the use of Moloney murine leukemia virus-reverse transcriptase and oligodeoxythymidylic acid (Life Technologies, Gaithersburg, MD, USA) at 37 C for 1 h. The sequences for the PRLR sense and antisense primers have been published previously (Banerjee et al. 1993) and were synthesized on a MilliGen 8750 DNA synthesizer (Millipore, Bedford, MA, USA). Primers for mouse glyceraldehyde 3-phosphate dehydrogenase (G3PDH), a ubiquitously expressed gene used as a control, were purchased from Clontech (Palo Alto, CA, USA). PCR was carried out using 5 µl reverse transcriptase product containing the cDNA, 200 n of each primer, 2·5 units Taq polymerase, and 0·2 m dNTPs. Amplificiation was performed on a Perkin Elmer Cetus PCR instrument (Perkin Elmer, Norwalk, CT, USA) for 30 cycles of 30 s at 94 C, 60 s at 60 C, 90 s at 72 C, and a final extension time of 5 min at 72 C. The PCR procedure was standardized for the amount of RNA and number of cycles so that the conditions used were in the linear range (Banerjee et al. 1993) . One-tenth of the PCR product was electrophoresed on a 2% agarose gel and stained with ethidium bromide. A predicted band of 318 bp for the PRLR or 983 bp for G3PDH was seen. The image of the gel was digitized using NIH Image and the results were normalized to G3PDH.
RESULTS
A previous study from this laboratory demonstrated that mammary explants from MMTV+ mice were more sensitive to PRL than those from MMTV animals and that the latter tissue could be rendered more sensitive to PRL when it was cultured in the presence of an MMTV receptor agonist (Bolander 1994b ). To determine if this effect was receptor-related, PRLRs were measured in the plasma membranes of mammary epithelium. There were twice as many PRLRs in MMTV+ vs MMTV mice (423 49 vs 183 32 fmol/100 µg protein respectively; P<0·05); there was no difference in the affinity constants between the two groups (Fig. 2) . Furthermore, gp52 could double PRLRs in tissue from MMTV animals during culture (409 77 fmol/100 µg; P<0·05 vs untreated MMTV ). This increase in PRLRs in the plasmalemma could be accomplished in any of three ways: (1) there could be an enhanced synthesis of PRLRs, (2) there could be a decreased degradation of PRLRs, or (3) PRLRs could be recruited from internal pools. These processes are not necessarily mutually exclusive.
PRLR synthesis was estimated from PRLR mRNA levels. Initial studies indicated that mammary epithelium from MMTV+ mice had twice the PRLR mRNA than tissue from MMTV animals (data not shown). To determine if this phenomenom could be reproduced in vitro, explants from MMTV mice were cultured in insulin and cortisol in the presence or absence of gp52. Figures 3 and 4 show that the MMTV envelope protein was able to induce PRLR mRNA nearly fivefold (P<0·05).
The rate of degradation of PRLRs was estimated from the PRLR half-life determined in the presence of cycloheximide. As can be seen in Fig. 5 , PRLRs decayed logarithmically with a half-life of approximately 3 h for mouse explants cultured with or without gp52. This is similar to the value reported for rabbit mammary explants using the same technique (Djiane et al. 1979) .
Finally, receptor redistribution was determined by measuring PRLRs on membrane fractions at various times after the addition of gp52 to cultured tissue. In fresh tissue, about two-thirds of the PRLRs were located intracellularly (Fig. 6) . However, within 30 min of the addition of gp52, there was a reversal of this distribution, resulting in the doubling of the PRLRs on the cell surface. There was no change in PRLR location in epithelium cultured without gp52. The difference between the intracellular and extracellular receptor content was significant (P<0·05).
DISCUSSION
The PRLR is unusual in that the majority of receptors in the unstimulated tissue are located  3. Ethidium bromide-stained 2% agarose gels of PRLR mRNA (top) and G3PDH mRNA (bottom) obtained from mammary epithelium cultured for 1 day in hormones with (lanes 6-10) or without gp52 (lanes 1-5). mRNA for PRLR or G3PDH was determined by RT-PCR and a band of predicted size of 318 bp or 983 bp respectively was seen.
 4. Relative PRLR mRNA levels in mammary epithelium cultured for 1 day in hormones with or without gp52. A photograph of the bands in ethidium bromide-stained 2% agarose gels (Fig. 3) was digitized using NIH Image and the results were normalized to G3PDH. The data are expressed as means ... of five experiments.
 5. PRLR half-life in mammary explants from MMTV mice. Mammary explants were cultured with cycloheximide (10 µg/ml) with () or without gp52 () and PRLRs were measured at the indicated times. The data points at 8 h are superimposed.
intracellularly. This phenomenon was first noted by Posner et al. (1979) for PRLRs in rat liver and later confirmed by Sakai et al. (1994) for PRLRs in the mouse mammary gland. That these sites might be recruited to the plasmalemma in response to physiological stimuli was suggested by Knazek et al. (1978) , who reported that growth hormone could induce PRLRs in mouse liver in the presence of cycloheximide, which would block new receptor synthesis. Bhattacharya & Vonderhaar (1979) performed similar experiments in the mammary gland, where they showed that thyroid hormones could induce PRLRs in the presence of puromycin. Finally, Costlow & Hample (1980 and Costlow (1984) may have unknowingly discovered the same phenomenon: they observed that energy depletion unmasked 'cryptic' PRLRs and that differentiation, which increases cell surface PRLRs, decreased these hidden receptors. Although they claimed that these 'cryptic' PRLRs were on the plasma membrane, they only determined the location after energy depletion; in retrospect, their data were compatible with the 'cryptic' PRLRs being internal and with their being translocated to the surface during differentiation. The data in this study demonstrate that the MMTV can also recruit PRLRs from an internal pool to the plasma membrane.
In addition to PRLR redistribution, the MMTV also appears to increase PRLR synthesis as estimated from mRNA levels. However, the degree of increase in PRLR mRNA is greater than the increase in PRLR number. It is likely that there are additional controls post-transcriptionally that limit the amount of PRLR synthesized from this mRNA. Alternatively, because of the magnitude of the standard error of the means, the magnitude of mRNA elevation may have been overestimated.
Another mechanism by which MMTV could elevate PRLRs would involve PRLR degradation, impairment of which would result in more efficient recycling and higher numbers of surface receptors. There is actually a precedent for this mechanism in viral infections: the E5 protein of the human papillomavirus binds to and inhibits the vacuolar proton-ATPase, which is required for the proper acidification of endosomes (Straight et al. 1995) . As a result, the internalized epidermal growth factor receptor escapes destruction and is recycled to the cell surface where it mediates cellular proliferation.
The strongest evidence that this mechanism might operate for PRLRs in the mammary gland comes from the rabbit. Like the EGFR in the example above (Edery et al. 1989) , the PRLR is strongly down-regulated in rabbit mammary glands (Djiane et al. 1982) ; furthermore, reducing PRLR degradation by lysosomotropic amines results in the elevation of PRLRs (Djiane et al. 1980) . Therefore, in this species, the inhibition of PRLR degradation appears to enhance recycling and increase receptor numbers. However, the data are not as strong in the mouse, where PRLRs do not seem to be downregulated (Ormandy & Sutherland 1993) and where lysosomotropic amines have no effect on PRLinduced -lactalbumin production at maximal prolactin concentrations (Bolander 1996) . This is further supported by Fig. 5 which shows that an alteration of the PRLR half-life is not involved in the MMTV induction of PRLRs.
In summary, this work presents several interesting concepts. First, a virus may affect cells by alternating plasma membrane receptors for hormones. Second, these changes in receptor concentrations can be made very quickly by recruiting receptors stored in internal pools. Finally, hormone receptors may be regulated at several different levels simultaneously.
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